Advancing Breakthrough Treatments for a Novel Class of Neurodegenerative Targets in Alzheimer’s Disease
July 22, 2021
Cognito Therapeutics Announces Upcoming Data Presentations at the Alzheimer’s Association International Conference 2021
July 14, 2021
Cognito Therapeutics Appoints Gerald Chan as Chairman of the Board
July 6, 2021
Cognito Therapeutics Initiates Studies in Down Syndrome Associated Alzheimer’s Disease
June 14, 2021
Moving Beyond Traditional Approaches to Alzheimer’s Disease
June 8, 2021
Cognito Therapeutics Appoints Everett Crosland as Chief Commercial Officer
May 18, 2021
Cognito Therapeutics Appoints Jonathan Lieber as Chief Financial Officer
May 5, 2021
MCIT Ruling Increases Access to Digital Therapeutic Innovation
May 3, 2021
Does Synchronizing Brain Waves Bring Harmony?
April 14, 2021
Please